John Roosa

Company: Merck & Co.

Job title: Director of Engineering, MRL New Technology Development & Potent Containment

Seminars:

Panel Discussion: The Future of HPAPIs, Cost/Risk Analysis & Advanced Manufacturing 10:00 am

As pipelines become more potent, for which indications is costly single nanogram containment cost beneficial for? Contrasting rare disease and wide-spread indications How can we better target drugs to efficaciously apply HPAPI’s for patient benefit? • How are analytical cleaning methods affected, given very low (single particle like) concentrations won’t be distributed like a gas…Read more

day: Day One

Utilizing Advanced Technologies for the Ultra High Potent Facility of the Future 9:00 am

• Creating and Utilizing an Interactive Virtual Reality Environment • Creating and implementing layers of protection to ensure both reduction of personnel exposure and facility migration of potent compounds • Utilizing innovative approaches to ensure success despite global COVID compliance • The convergence of ultra-potent and “modality agnostic” compoundsRead more

day: Day One